Alisha Ahmed, Director, Lymphoma US HCP Marketing at Pfizer, shared on LinkedIn:
“Reflecting on the DAVA Summit on Hematologic Malignancies and the conversations that made the week so valuable. There’s something about being in a room with people who care about the same work that’s hard to replicate. The peer-to-peer exchange, new connections, and different perspectives are such an important part of why showing up in person matters.
Grateful to everyone who made time to connect.”
You can also read Hematologic Malignancies: Therapeutic Success Amid Epidemiological Failure on OncoDaily.
